French doctors prescribe more patented statins than their European counterparts. The country’s health service spends €1.2 billion on statins every year, double the budget of some European countries. EurActiv France reports .
Europe will face an obesity crisis of vast proportions by 2030, according to new World Health Organization projections, with many countries likely to see far more than half of adults above the healthy weight limit.
FH is an inherited condition associated with high “bad” cholesterol (low-density lipoprotein-cholesterol or LDL-C) and may predispose a person to premature cardiovascular disease (CVD). People with FH are unable to process the body’s natural supply of cholesterol, leading to very high levels of “bad” cholesterol that can block arteries and lead to a heart attack or stroke.
A recent report by the French Directorate for Research, Studies and the Evaluation of Statistics (DREES) has placed France ahead of its EU partners in terms of cardiovascular health, despite a relatively high rate of smoking among young people. EurActiv France reports .
American researchers believe that 97% of people over the age of 66 should regularly take statins to reduce their risk of heart disease. But there is still no consensus within the medical community on the benefits of the drugs. EurActiv France reports .
Heart disease is the leading cause of death in Europe, claiming about four million victims each year. Some regions are affected to a much greater extent than others, and disparities are clearly visible both on a national level and across the continent. EurActiv France reports.
A new generation of anticoagulants have been blamed for the deaths of patients in France. Studies from two leading French health agencies conclude that they do not pose a serious risk, but doubts remain. EurActiv France reports .
Cardiovascular disease is the number one killer in the EU, but it is not yet given enough importance on the political agenda, according to Tonio Borg, who has scheduled an EU summit on chronic diseases at the beginning of next year.
Cardiovascular disease accounts for more deaths than any other disease in the EU, and though it has received a lot of attention over the past decades, much more needs to be done at EU level, experts say.
In an exclusive interview with EurActiv journalists Henriette Jacobsen and Evan Lamos, EU Commissioner for Health Tonio Borg said that fighting cardiovascular diseases should be 'higher on the political agenda', as it is the number one killer disease in the EU. Borg also announced that he is launching an EU summit on chronic diseases at the beginning of next year.
The number of people dying from heart disease in Europe has dropped dramatically in recent decades, thanks largely to the success of cholesterol-lowering drugs and drives to persuade people to quit smoking, scientists said on Wednesday (25 June).
Too few women are taking part in clinical tests to develop new drugs, putting their lives at risk as women's bodies react differently to medicines, health experts said ahead of International Women's Day.
The lack of gender balance in clinical tests affects almost all medical sectors, but is particularly relevant in cardiovascular diseases where only 33% of trials participants are women. On International Women's Day, Marco Stramba-Badiale is calling for an update of the EU's Clinical Trials Directive to address this imbalance.
Clinical research conducted by the Medical University of South Carolina, Charleston, shows that adopting a healthy lifestyle, even at middle age, promptly reduces the risk of cardiovascular diseases and early death.